Sourcebio International Plc (LON:SBI – Get Free Report) rose 4.5% during trading on Thursday . The stock traded as high as GBX 125 ($1.58) and last traded at GBX 115 ($1.45). Approximately 1,571,282 shares traded hands during mid-day trading, an increase of 931% from the average daily volume of 152,444 shares. The stock had previously closed at GBX 110 ($1.39).
Sourcebio International Trading Up 4.5 %
The company has a 50 day moving average of GBX 115 and a 200 day moving average of GBX 115. The company has a debt-to-equity ratio of 35.10, a quick ratio of 1.78 and a current ratio of 1.91. The stock has a market capitalization of £85.31 million and a price-to-earnings ratio of 1,277.78.
Sourcebio International Company Profile
Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services.
Recommended Stories
- Five stocks we like better than Sourcebio International
- Comparing and Trading High PE Ratio Stocks
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Investing In Automotive Stocks
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- How to buy stock: A step-by-step guide for beginners
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Sourcebio International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sourcebio International and related companies with MarketBeat.com's FREE daily email newsletter.